Search results

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 IPRO Day Presentation F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Abstract F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Poster F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Midterm Presentation F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: ACCELPharma (semester?), IPRO 353
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Final Report F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: Searching for Novel Drug Targets (semester?), IPRO 318: Searching for Novel Drug Targets IPRO 318 Poster F07
Creator: Amin, Kathan, Himchak, Evan, Hu, Xiao-xuan, Huang, Suyao, Laster, Kyle, Lee, Hyun, Liu, Alfred, Nedrud, Joshua, Pansara, Megha, Topagi, Snehalata, Wicker, Amanda, Zwibelman, Hannah
Date: 2007-12, 2007-12
Description: Over the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to...
Show moreOver the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to find potential drug targets on pathogenic proteins. During past terms, IPRO 318 has compiled information on proteins that are known to be involved in diseases in a disease gene database. By comparing this to a database of hypothetical genes, possible high value proteins were found. This term IPRO 318 continued the lab work on the high value proteins found in previous semesters, found new ones and began lab work on those proteins, continued work on the databases, and started a new allergen database.
Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2007 semester
Show less

Title: Searching for Novel Drug Targets (semester?), IPRO 318
Creator: Amin, Kathan, Himchak, Evan, Hu, Xiao-xuan, Huang, Suyao, Laster, Kyle, Lee, Hyun, Liu, Alfred, Nedrud, Joshua, Pansara, Megha, Topagi, Snehalata, Wicker, Amanda, Zwibelman, Hannah
Date: 2007-12, 2007-12
Description: Over the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to...
Show moreOver the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to find potential drug targets on pathogenic proteins. During past terms, IPRO 318 has compiled information on proteins that are known to be involved in diseases in a disease gene database. By comparing this to a database of hypothetical genes, possible high value proteins were found. This term IPRO 318 continued the lab work on the high value proteins found in previous semesters, found new ones and began lab work on those proteins, continued work on the databases, and started a new allergen database.
Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2007 semester
Show less

Title: Searching for Novel Drug Targets (semester?), IPRO 318: Searching for Novel Drug Targets IPRO 318 Final Report F07
Creator: Amin, Kathan, Himchak, Evan, Hu, Xiao-xuan, Huang, Suyao, Laster, Kyle, Lee, Hyun, Liu, Alfred, Nedrud, Joshua, Pansara, Megha, Topagi, Snehalata, Wicker, Amanda, Zwibelman, Hannah
Date: 2007-12, 2007-12
Description: Over the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to...
Show moreOver the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to find potential drug targets on pathogenic proteins. During past terms, IPRO 318 has compiled information on proteins that are known to be involved in diseases in a disease gene database. By comparing this to a database of hypothetical genes, possible high value proteins were found. This term IPRO 318 continued the lab work on the high value proteins found in previous semesters, found new ones and began lab work on those proteins, continued work on the databases, and started a new allergen database.
Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2007 semester
Show less

repository.iit

Search the repository

Query

Enabled Filters

Refine Results

Type

Date

Subject

Creator

Rights